Product Information
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP is a generic product labeled by Viona Pharmaceuticals Inc., priced at $0.1221 per EA under NDC 72578009001. Its NADAC has been published 281 times since Apr 7, 2021.
FDA first approved this application on Feb 11, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 37.5 mg/1; mg/1
Manufacturer
Viona Pharmaceuticals Inc.NDC
72578009001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; TRIAMTERENEApproval Type
Generic (ANDA)
FDA Application
ANDA208358FDA Approved
2/11/2019
TE Code
AB
On Market Since
2/21/2020
Pharmacological Classes
Price Statistics
The NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP has been published 281 times since Apr 7, 2021, and over the history we have for it it has declined 19.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1221 per EA |
|---|---|
| All-time high | $0.1577 (May 12, 2021) |
| All-time low | $0.0844 (Jul 17, 2024) |
| 52-week high | $0.1221 |
| 52-week low | $0.1128 |
| Median price | $0.1236 |
| Average price | $0.1261 |
| Largest weekly change | +46.0% (Aug 21, 2024) |
| Weeks tracked | 281 |
| Tracking since | Apr 7, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP, manufactured by Viona Pharmaceuticals Inc., is $0.1221 per EA (NDC 72578009001), effective Aug 19, 2026.
How has the price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP changed over time?
Over the history we have for it, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP has declined 19.0%. It has been tracked across 281 weekly CMS publications since Apr 7, 2021.
What are the highest and lowest recorded NADAC prices for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP?
Since Apr 7, 2021, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP has ranged from a low of $0.0844 (Jul 17, 2024) to a high of $0.1577 (May 12, 2021), with a median of $0.1236 per EA.
Are there cheaper alternatives to TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP?
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP (NDC 72578009001) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.